Implementing a Multicomponent Navigation Program to Reduce Time Intervals to Treatment Initiation for Advanced Breast Cancer in Paraguay

JCO Global Oncology · Published 2026-04-01 · DOI 10.1200/go-25-00281

Authors being retrieved — see the publisher record. https://doi.org/10.1200/go-25-00281

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Physician Perceptions Toward Palliative Care Integration in Childhood Cancer Care in Asia Pacific · JCO Global Oncology · 2026 · Same journal
China's Growing Importance in Global Cancer Medicines · JCO Global Oncology · 2026 · Same journal
Expression of Concern: Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial · JCO Global Oncology · 2026 · Same journal
Clinical Research Capacity Building in Pediatric Oncology in Resource-Limited Settings: Application and Early Results of Regional Educational Workshops · JCO Global Oncology · 2026 · Same journal
Cancer Frequencies and Screening in Individuals With Down Syndrome: A Comprehensive Nationwide Cross-Sectional Analysis · JCO Global Oncology · 2026 · Same journal
Targeting Inequities: Addressing Lung Cancer Care Challenges in Africa Through Drug Access, Radiotherapy, and Surgical Innovations · JCO Global Oncology · 2026 · Same journal
Evaluating the Impact of a Patient Navigation Program on Treatment Timeliness, Continuity, and Follow-Up Outcomes for Patients With Digestive Tract Cancer at Kenyatta Hospital · JCO Global Oncology · 2026 · Same journal
Prevalence and Factors Associated With Financial Toxicity Among Patients With GI Cancer in Pakistan · JCO Global Oncology · 2026 · Same journal
Concurrent New Systemic Therapies and Radiation Therapy in Breast Cancer: Current Evidence, Future Challenges, and Expert Practice Recommendations for Low- and Middle-Income Countries · JCO Global Oncology · 2026 · Same journal
Beyond Testing: Rethinking Access in Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer · JCO Global Oncology · 2026 · Same journal